Tata Chemicals Limited
Regd. Office: Bombay House, 24 Homi Mody Street, Mumbai - 400 001
Statement of Consolidated Financial Results for the quarter and year ended 31 March, 2026
(` in crore)
Particulars Quarter Quarter Quarter Year Year
ended ended ended ended ended
31 31 31 31 31
March, December, March, March, March,
2026 2025 2025 2026 2025
(Audited) (Unaudited) (Audited) (Audited) (Audited)
(note 5) (note 5)
1 Income
a) Revenue from operations 3,438 3,550 3,509 14,584 14,887
b) Other income 44 38 42 316 225
Total income (1a + 1b) 3,482 3,588 3,551 14,900 15,112
2 Expenses
a) Cost of materials consumed 688 710 580 2,958 2,560
b) Purchases of stock-in-trade 56 33 84 305 290
c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (73) 69 45 (79) 28
d) Employee benefits expense 524 505 484 2,060 1,989
e) Power and fuel 460 444 593 1,799 2,421
f) Freight and forwarding charges 768 767 735 2,955 2,736
g) Finance costs 153 146 137 590 563
h) Depreciation and amortisation expense 343 293 293 1,201 1,123
i) Other expenses 741 677 661 2,781 2,910
Total expenses (2a to 2i) 3,660 3,644 3,612 14,570 14,620
3 (Loss)/profit before exceptional items, share of profit of joint ventures and associate
and tax (1-2) (178) (56) (61) 330 492
4 Exceptional items (net) (note 2) (1,837) (54) (55) (1,956) (125)
5 (Loss)/profit before share of profit of joint ventures and associate and tax (3+4) (2,015) (110) (116) (1,626) 367
6 Share of profit of joint ventures and associate (net of tax) 33 37 24 167 154
7 (Loss)/profit before tax (5+6) (1,982) (73) (92) (1,459) 521
8 Tax expenses
a) Current tax (note 3(a)) 19 20 (34) 172 126
b) Deferred tax 115 (24) 9 84 41
Total tax expenses (8a + 8b) 134 (4) (25) 256 167
9 (Loss)/profit from continuing operations after tax (7-8) (2,116) (69) (67) (1,715) 354
10 Exceptional gain from discontinued operations (note 4) - - 27 - 47
11 Tax expenses of discontinued operations - - 9 - 14
12 Profit from discontinued operations after tax (10-11) - - 18 - 33
13 (Loss)/profit for the period (9+12) (2,116) (69) (49) (1,715) 387
14 Other comprehensive income ('OCI') - gain/(loss)
a) (i) Items that will not be reclassified to the Consolidated Statement of Profit and
Loss
- Change in fair value of equity investments carried at fair value through OCI (536) 877 (137) 853 (621)
- Remeasurement of defined employee benefit plans 194 (5) 162 173 169
(ii) Income Tax relating to above items - charge (note 3(b)) (45) 84 - 109 80
(iii) Share of other comprehensive credit /(charge) of joint ventures (net of tax) (66) 69 (49) 10 (216)
b) (i) Items that will be reclassified to the Consolidated Statement of Profit and Loss
- Effective portion of cash flow hedges 65 (12) 33 31 65
- Changes in foreign currency translation reserve 416 105 (34) 818 191
(ii) Income Tax relating to above items - charge 1 (2) 5 (5) 11
(iii) Share of other comprehensive (charge) / credit of joint ventures (net of tax) 6 1 - 9 2
Total other comprehensive income (net of tax) (a(i-ii+iii)+b(i-ii+iii)) 123 953 (30) 1,790 (501)
15 Total comprehensive income for the period (13+14) (1,993) 884 (79) 75 (114)
16 (Loss)/profit from continuing operations after tax (9)
Attributable to:
Equity shareholders of the Company (2,132) (93) (74) (1,896) 202
Non-controlling interests 16 24 7 181 152
(2,116) (69) (67) (1,715) 354
17 Profit from discontinued operations after tax (12)
Attributable to:
Equity shareholders of the Company - - 18 - 33
Non-controlling interests - - - - -
- - 18 - 33
18 (Loss)/profit for the period (13)
Attributable to:
Equity shareholders of the Company (2,132) (93) (56) (1,896) 235
Non-controlling interests 16 24 7 181 152
(2,116) (69) (49) (1,715) 387
19 Other comprehensive income - gain/(loss) (net of tax) (14)
Attributable to:
Equity shareholders of the Company 121 952 (29) 1,788 (500)
Non-controlling interests 2 1 (1) 2 (1)
123 953 (30) 1,790 (501)
20 Total comprehensive income for the period (15)
Attributable to:
Equity shareholders of the Company (2,011) 859 (85) (108) (265)
Non-controlling interests 18 25 6 183 151
(1,993) 884 (79) 75 (114)
21 Paid-up equity share capital
(Face value : ` 10 per Share) 255 255 255 255 255
22 Other equity and Non-controlling interests 21,920 22,246
23 Earnings per share for continuing operations (in `)
- Basic and Diluted (83.68)* (3.65)* (2.90)* (74.42) 7.93
24 Earnings per share for discontinued operations (in `)
- Basic and Diluted - - 0.71* - 1.30
25 Earnings per share for continuing and discontinued operations (in `)
- Basic and Diluted (83.68)* (3.65)* (2.19)* (74.42) 9.23
* Not annualised
See annexed segment information, balance sheet, cash flow, additional information
pursuant to Regulation 52(4) and accompanying notes to the consolidated financial
results